All filers

SIC major group 28

Chemicals and allied products

619 comparable filers in this run name at least one classified risk family. 484 of them are named here; the others are withheld until both checks agree.

Risk families across the group

Counts over every comparable filer in the group, named or withheld.
FamilyFilers naming itFirst timeDid not
Tariff exposure619420

The filers 484

New this year 31

Carried over 453

4D Molecular Therapeutics, Inc., Aardvark Therapeutics, Inc., Abbott Laboratories, AbCellera Biologics Inc., Abvc Biopharma, Inc., Acadia Pharmaceuticals Inc, Acrivon Therapeutics, Inc., Actinium Pharmaceuticals, Inc., Acurx Pharmaceuticals, Inc., Adial Pharmaceuticals, Inc., Adicet Bio, Inc., Adma Biologics, Inc., AdvanSix Inc., Aemetis, Inc, AEON Biopharma, Inc., Agios Pharmaceuticals, Inc., Air Products & Chemicals, Inc., Akari Therapeutics Plc, Akebia Therapeutics, Inc., Albemarle Corp, Aldeyra Therapeutics, Inc., Alector, Inc., Aligos Therapeutics, Inc., Allogene Therapeutics, Inc., Alnylam Pharmaceuticals, Inc., Alpha Cognition Inc., Alpha Teknova, Inc., Alumis Inc., ALX Oncology Holdings Inc, American Vanguard Corp, Amgen Inc, Amicus Therapeutics, Inc., Amneal Pharmaceuticals, Inc., Amphastar Pharmaceuticals, Inc., AN2 Therapeutics, Inc., Anavex Life Sciences Corp., Anebulo Pharmaceuticals, Inc., ANI Pharmaceuticals Inc, Apellis Pharmaceuticals, Inc., Aptose Biosciences Inc., Arcturus Therapeutics Holdings Inc., Arcus Biosciences, Inc., Arcutis Biotherapeutics, Inc., Ardelyx, Inc., Armata Pharmaceuticals, Inc., Arq, Inc., ArriVent BioPharma, Inc., Arrowhead Pharmaceuticals, Inc., ARS Pharmaceuticals, Inc., Arvinas, Inc., Ascend Wellness Holdings, Inc., Ascent Industries Co., ASP Isotopes Inc., Aspire Biopharma Holdings, Inc., Assertio Holdings, Inc., Atea Pharmaceuticals, Inc., aTYR PHARMA INC, Autolus Therapeutics plc, Avidity Biosciences, Inc., Avient Corp, Axalta Coating Systems Ltd., Axil Brands, Inc., Aytu Biopharma, Inc, Balchem Corp, Barinthus Biotherapeutics plc., Bausch Health Companies Inc., BeOne Medicines Ltd., BeyondSpring Inc., Bicara Therapeutics Inc., Bicycle Therapeutics PLC, BIO-TECHNE Corp, BioAge Labs, Inc., BioAtla, Inc., BioCardia, Inc., Biocryst Pharmaceuticals Inc, Biogen Inc., Biohaven Ltd., Biolargo, Inc., Biomarin Pharmaceutical Inc, Biomea Fusion, Inc., Biomerica Inc, Black Diamond Therapeutics, Inc., Bolt Biotherapeutics, Inc., Bonk, Inc., BriaCell Therapeutics Corp., Bristol Myers Squibb Co, C4 Therapeutics, Inc., Cabaletta Bio, Inc., Cabot Corp, Cadrenal Therapeutics, Inc., Calidi Biotherapeutics, Inc., Canopy Growth Corp, Capricor Therapeutics, Inc., Cardiff Oncology, Inc., Caribou Biosciences, Inc., Catalyst Pharmaceuticals, Inc., cbdMD, Inc., Celanese Corp, Celldex Therapeutics, Inc., Celularity Inc, CervoMed Inc., CF Industries Holdings, Inc., CG Oncology, Inc., Charlie's Holdings, Inc., Chemours Co, Church & Dwight Co Inc, Cingulate Inc., Citius Oncology, Inc., Citius Pharmaceuticals, Inc., Climb Bio, Inc., Clorox Co, Codexis, Inc., Cogent Biosciences, Inc., Coherus Oncology, Inc., Colgate Palmolive Co, Comstock Inc., Connect Biopharma Holdings Ltd, Contineum Therapeutics, Inc., Corbus Pharmaceuticals Holdings, Inc., Corcept Therapeutics Inc, Coty Inc., Coya Therapeutics, Inc., Crinetics Pharmaceuticals, Inc., Cronos Group Inc., Cryoport, Inc., CSW Industrials, Inc., Cue Biopharma, Inc., Cullinan Therapeutics, Inc., Curis Inc, CVR Partners, LP, Dare Bioscience, Inc., DBV Technologies S.A., Definium Therapeutics, Inc., Dermata Therapeutics, Inc., DiaMedica Therapeutics Inc., Dianthus Therapeutics, Inc., Disc Medicine, Inc., DOW Inc., DuPont de Nemours, Inc., Dyadic International Inc, e.l.f. Beauty, Inc., Eastman Chemical Co, Ecolab Inc., Ecovyst Inc., EDGEWELL PERSONAL CARE Co, Edgewise Therapeutics, Inc., Editas Medicine, Inc., Elanco Animal Health Inc, Element Solutions Inc, ELI LILLY & Co, Elicio Therapeutics, Inc., Elite Pharmaceuticals Inc, Elutia Inc., Emergent BioSolutions Inc., Emmaus Life Sciences, Inc., Enanta Pharmaceuticals Inc, enGene Therapeutics Inc., Enliven Therapeutics, Inc., Entrada Therapeutics, Inc., Erasca, Inc., Esperion Therapeutics, Inc., Estee Lauder Companies Inc, Eton Pharmaceuticals, Inc., Evolus, Inc., Exelixis, Inc., Fate Therapeutics Inc, Fennec Pharmaceuticals Inc., Fitlife Brands, Inc., Flexible Solutions International Inc, Flotek Industries Inc, FMC Corp, Foghorn Therapeutics Inc., Fortress Biotech, Inc., Fulcrum Therapeutics, Inc., Fuller H B Co, Gain Therapeutics, Inc., Genprex, Inc., Geron Corp, Ginkgo Bioworks Holdings, Inc., Global Gas Corp, Grace Therapeutics, Inc., Green Plains Inc., Greenland Mines Ltd, Greenwich LifeSciences, Inc., GT Biopharma, Inc., Gyre Therapeutics, Inc., Harmony Biosciences Holdings, Inc., Heron Therapeutics, Inc., Hexcel Corp, Highwater Ethanol LLC, Humacyte, Inc., Huntsman International LLC, IDEAYA Biosciences, Inc., Idexx Laboratories Inc, IGC Pharma, Inc., ImageneBio, Inc., Immix Biopharma, Inc., Immucell Corp, Immunocore Holdings plc, Immunome Inc., Immunovant, Inc., IN8BIO, Inc., Indivior Pharmaceuticals, Inc., Ingevity Corp, Inhibikase Therapeutics, Inc., Inhibrx Biosciences, Inc., InMed Pharmaceuticals Inc., Innospec Inc., Innoviva, Inc., Inovio Pharmaceuticals, Inc., Insight Molecular Diagnostics Inc., INSMED Inc, Instil Bio, Inc., International Flavors & Fragrances Inc, International Stem Cell CORP, Interparfums Inc, Invivyd, Inc., Ionis Pharmaceuticals Inc, Iovance Biotherapeutics, Inc., Janux Therapeutics, Inc., Jazz Pharmaceuticals plc, Johnson & Johnson, Journey Medical Corp, Jupiter Neurosciences, Inc., Kairos Pharma, LTD., Karyopharm Therapeutics Inc., Keenova Therapeutics plc, Kenvue Inc., Kiniksa Pharmaceuticals International, plc, Kodiak Sciences Inc., Korro Bio, Inc., Korsana Biosciences, Inc., Kronos Worldwide Inc, Kymera Therapeutics, Inc., Kyntra Bio, Inc., Kyverna Therapeutics, Inc., Lantheus Holdings, Inc., LanzaTech Global, Inc., Larimar Therapeutics, Inc., LeonaBio, Inc., Lexicon Pharmaceuticals, Inc., LFTD Partners Inc., Lifecore Biomedical, Inc. \DE\, Lifevantage Corp, Linde PLC, Lineage Cell Therapeutics, Inc., Liquidia Corp, Liquidmetal Technologies Inc, Lisata Therapeutics, Inc., Lomond Therapeutics Holdings, Inc., Longevity Health Holdings, Inc., LSB Industries, Inc., Lunai Bioworks Inc., Luxfer Holdings PLC, Lyell Immunopharma, Inc., LyondellBasell Industries N.V., Macrogenics Inc, Mannatech Inc, Mannkind Corp, Maravai Lifesciences Holdings, Inc., Matinas BioPharma Holdings, Inc., Maze Therapeutics, Inc., MBX Biosciences, Inc., Medicinova Inc, Medicus Pharma Ltd., Merck & Co., Inc., Mereo BioPharma Group plc, Metagenomi Therapeutics, Inc., MetaVia Inc., Milestone Pharmaceuticals Inc., Minerals Technologies Inc, Mineralys Therapeutics, Inc., Minerva Neurosciences, Inc., Mira Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc., Moderna, Inc., Moleculin Biotech, Inc., Monopar Therapeutics, Monte Rosa Therapeutics, Inc., MoonLake Immunotherapeutics, Mosaic Co, Mustang Bio, Inc., Myriad Genetics Inc, Natural Alternatives International Inc, Natures Sunshine Products Inc, Nektar Therapeutics, Neogen Corp, Neuphoria Therapeutics Inc., Neurocrine Biosciences Inc, Newmarket Corp, Nexentis Technologies Inc., Niagen Bioscience, Inc., NLI Holdings, Inc., Novavax Inc, NRX Pharmaceuticals, Inc., Nurix Therapeutics, Inc., Nuvalent, Inc., Nuvation Bio Inc., Nuvectis Pharma, Inc., Ocugen, Inc., Ocular Therapeutix, Inc, Olaplex Holdings, Inc., Olema Pharmaceuticals, Inc., Omeros Corp, Organogenesis Holdings Inc., Organon & Co., Origin Materials, Inc., Orion S.A., Ovid Therapeutics Inc., Pacira BioSciences, Inc., Palisade Bio, Inc., Pasithea Therapeutics Corp., Passage BIO, Inc., Perimeter Solutions, Inc., PERRIGO Co plc, Perspective Therapeutics, Inc., Pfizer Inc, PharmaCyte Biotech, Inc., Phathom Pharmaceuticals, Inc., Phibro Animal Health Corp, Pluri Inc., PMGC Holdings Inc., PMV Pharmaceuticals, Inc., Polomar Health Services, Inc., PPG Industries Inc, Praxis Precision Medicines, Inc., Precision Biosciences Inc, Prestige Consumer Healthcare Inc., Prime Medicine, Inc., Processa Pharmaceuticals, Inc., PROCTER & GAMBLE Co, Prokidney Corp., Protara Therapeutics, Inc., PTC Therapeutics, Inc., Puma Biotechnology, Inc., PureCycle Technologies, Inc., Pyxis Oncology, Inc., Q32 Bio Inc., QuidelOrtho Corp, Rapport Therapeutics, Inc., Recursion Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., REGENXBIO Inc., Rein Therapeutics, Inc., Relay Therapeutics, Inc., Relmada Therapeutics, Inc., Repligen Corp, Replimune Group, Inc., Revelation Biosciences, Inc., Reviva Pharmaceuticals Holdings, Inc., REX AMERICAN RESOURCES Corp, Rhythm Pharmaceuticals, Inc., Rigel Pharmaceuticals Inc, Rocket One Inc., Rocket Pharmaceuticals, Inc., Rockwell Medical, Inc., Rogers Corp, Roivant Sciences Ltd., Royalty Pharma plc, RPM International Inc, SAB Biotherapeutics, Inc., Sana Biotechnology, Inc., Sangamo Therapeutics, Inc, Savara Inc, Scienture Holdings, Inc., Scilex Holding Co, Scotts Miracle-Gro Co, Sealed Air Corp, SenesTech, Inc., Sensient Technologies Corp, Senti Biosciences Holdings, Inc., Septerna, Inc., Seres Therapeutics, Inc., Shattuck Labs, Inc., Siga Technologies Inc, Sionna Therapeutics, Inc., Skye Bioscience, Inc., Soleno Therapeutics Inc, Solid Biosciences Inc., Soligenix, Inc., Sonnet BioTherapeutics Holdings, Inc., Spero Therapeutics, Inc., Spyre Therapeutics, Inc., Standard Biotools Inc., Stepan Co, Stoke Therapeutics, Inc., Structure Therapeutics Inc., Summit Therapeutics Inc., Talphera, Inc., Tango Therapeutics, Inc., Tarsus Pharmaceuticals, Inc., Taysha Gene Therapies, Inc., Tectonic Therapeutic, Inc., Tenaya Therapeutics, Inc., Terns Pharmaceuticals, Inc., Theravance Biopharma, Inc., Theriva Biologics, Inc., Tilray Brands, Inc., TOMI Environmental Solutions, Inc., Tonix Pharmaceuticals Holding Corp., Travere Therapeutics, Inc., Traws Pharma, Inc., Trevi Therapeutics, Inc., Trinseo PLC, Tronox Holdings plc, TScan Therapeutics, Inc., Twist Bioscience Corp, Tyra Biosciences, Inc., Union Carbide Corp, uniQure N.V., UNITED THERAPEUTICS Corp, Upstream Bio, Inc., Usana Health Sciences Inc, Valhi Inc, Valion Bio, Inc., Vanda Pharmaceuticals Inc., Vaxart, Inc., Vaxcyte, Inc., Vera Therapeutics, Inc., Verde Clean Fuels, Inc., Vericel Corp, Verrica Pharmaceuticals Inc., Vertex Pharmaceuticals Inc / MA, Viatris Inc, Vir Biotechnology, Inc., Viridian Therapeutics, Inc.\DE, Vistagen Therapeutics, Inc., Vitro Biopharma, Inc., VivoSim Labs, INC., Volitionrx Ltd, Vor Biopharma Inc., Voyager Therapeutics, Inc., Wave Life Sciences, Inc., WD 40 Co, Werewolf Therapeutics, Inc., Westlake Chemical Partners LP, Westlake Corp, Whitehawk Therapeutics, Inc., XBiotech Inc., Xencor Inc, Xenon Pharmaceuticals Inc., Xeris Biopharma Holdings, Inc., Xilio Therapeutics, Inc., XOMA Royalty Corp, Yarrow Bioscience, Inc., Zai Lab Ltd, Zenas BioPharma, Inc., Zentalis Pharmaceuticals, Inc., Zevra Therapeutics, Inc., Zoetis Inc., Zomedica Corp., Zura Bio Ltd, Zymeworks Inc.

Not comparable, and not counted 12

Their prior 10-K cannot support a new-or-carried verdict (a cut-down, shell or empty Item 1A), so they are in none of the figures above, and they are not named.